CareDx, Inc.
NASDAQCareDx enters September with a split personality: a Canaccord Genuity initiation at Buy with a $65 target landed this morning, yet the stock is down 3.6% on the week and carrying an 11.2% short interest that has barely budged. The tension between an improving analyst consensus and a still-elevated short base is the defining feature of this setup. The Street is moving more…
CDNA short interest falls 30% in one week to 10.7% of float as covering accelerates ahead of earnings.
Snapshot as of 15 Sept 2026
CareDx enters September with a split personality: a Canaccord Genuity initiation at Buy with a $65 target landed this morning, yet the stock is down 3.6% on the week and carrying an 11.2% short interest that has barely…
CareDx heads into its August 4 earnings report carrying the imprint of a dramatic short squeeze — and a CEO who sold into it. The most striking development in the run-up is how aggressively short sellers have…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CDNA — free to start on ORTEX.
Sign up for free →Open CDNA on ORTEX